A new endogenous form of PYY isolated from canine ileum: Gly-extended PYY(1-36)

Regulatory Peptides

Volumn 151, Issue 1-3, 2008, Pages 61-70

  Keire, David A ^a   Whitelegge, Julian P ^b   Bassilian, Sara ^b   Faull, Kym F ^b   Wiggins, Brian W ^a   Mehdizadeh, Omid B ^a   Reidelberger, Roger D ^c,d   Haver, Alvin C ^c   Sayegh, Ayman I ^e   Reeve Jr , Joseph R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

^d CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Nursing and Allied Health   (United States)

Author keywords

Canine ileum; DPP IV; PYY(1 36); PYY(1 36) Gly; PYY(3 36); Top down MS

Indexed keywords

PEPTIDE YY;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CECUM; DOG; ILEUM; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; REVERSED PHASE LIQUID CHROMATOGRAPHY; TISSUE LEVEL;

AMINO ACID SEQUENCE; ANIMALS; DOGS; ILEUM; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; PEPTIDE YY; RADIOIMMUNOASSAY; SEQUENCE HOMOLOGY, AMINO ACID; TISSUE DISTRIBUTION;

EID: 56549129016     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2008.04.001     Document Type: Article

References (72)

1. Tatemoto K., and Mutt V. Chemical determination of polypeptide hormones. Proc Natl Acad Sci U S A 75 (1978) 4115-4119
2. Tatemoto K., and Mutt V. Isolation of two novel candidate hormones using a chemical method for finding naturally occurring polypeptides. Nature 285 (1980) 417-418
3. Bottcher G., Alumets J., Hakanson R., and Sundler F. Co-existence of glicentin and peptide YY in colorectal L-cells in cat and man. An electron microscope study. Regul Pept 13 (1986) 283-291
4. Greeley G.H.J., Jeng Y.J., Gomez G., Hashimoto F.I., Hill K., Kern K., Kurosky T., Chuo H.F., and Thompson J.C. Evidence for regulation of peptide-YY release by the proximal gut. Endocrinology 124 (1989) 1438-1443
5. Grandt D., Schimiczek M., Beglinger C., Layer P., Goebell H., Eysselein V.E., and Reeve J.R.J. Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36. Regul Pept 51 (1994) 151-159
6. Batterham R.L., Cowley M.A., Small C.J., Herzog H., Cohen M.A., Dakin C.L., Wren A.M., Brynes A.E., Low M.J., Ghatei M.A., Cone R.D., and Bloom S.R. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 418 (2002) 650-654
7. Chelikani P.K., Haver A.C., and Reidelberger R.D. Intravenous infusion of peptide YY(3-36) potently inhibits food intake in rats. Endocrinology 146 (2005) 879-888
8. Beglinger C., and Degen L. Gastrointestinal satiety signals in humans-physiologic roles for GLP-1 and PYY?. Physiol Behav 89 (2006) 460-464
9. Adrian T.E., Savage A.P., Sagor G.R., Allen J.M., Bacarese-Hamilton A.J., Tatemoto K., Polak J.M., and Bloom S.R. Effect of peptide YY on gastric, pancreatic, and biliary function in humans. Gastroenterology 89 (1985) 494-499
10. Bilchik A.J., Hines O.J., Adrian T.E., McFadden D.W., Berger J.J., Zinner M.J., and Ashley S.W. Peptide YY is a physiological regulator of water and electrolyte absorption in the canine small bowl in-vivo. Gastroenterology 105 (1993) 1441-1448
11. Chen C.H., and Rogers R.C. Central inhibitory action of peptide YY on gastric motility in rats. Am J Physiol 269 (1995) R787-R792
12. Pappas T.N., Debas H.T., and Taylor I.I. Enterogastrone-like effect of peptide YY is vagally mediated in the dog. J Clin Invest 77 (1986) 49-53
13. Putnam W.S., Liddle R.A., and Williams J.A. Inhibitory regulation of rat exocrine pancreas by peptide YY and pancreatic polypeptide. Am J Physiol 256 (1989) G698-G703
14. Whang E.E., Hines O.J., Reeve J.R.J., Grandt D., Moser J.A., Bilchik A.J., Zinner M.J., McFadden D.W., and Ashley S.W. Antisecretory mechanisms of peptide YY in rat distal colon. Dig Dis Sci 42 (1997) 1121-1127
15. Chelikani P.K., Haver A.C., and Reidelberger R.D. Comparison of the inhibitory effects of PYY(3-36) and PYY(1-36) on gastric emptying in rats. Am J Physiol Regul Integr Comp Physiol 287 (2004) R1064-R1070
16. Pironi L., Stanghellini V., Miglioli M., Corinaldesi R., De Giorgio R., Ruggeri E., Tosetti C., Poggioli G., Morselli Labate A.M., Monetti N., et al. Fat-induced ileal brake in humans: a dose-dependent phenomenon correlated to the plasma levels of peptide YY. Gastroenterology 105 (1993) 733-739
17. Dockray G.D., and Walsh J.H. Regulatory peptide systems of the gut. In: Walsh J.H., and Dockray G.J. (Eds). Gut peptides: biochemistry and physiology (1994), Raven Press, New York 1-9
18. Siuti N., and Kelleher N.L. Decoding protein modifications using top-down mass spectrometry. Nat Methods 4 (2007) 817-821
19. Whitelegge J., Halgand F., Souda P., and Zabrouskov V. Top-down mass spectrometry of integral membrane proteins. Expert Rev Proteomics 3 (2006) 585-596
20. Zabrouskov V., and Whitelegge J.P. Increased coverage in the transmembrane domain with activated-ion electron capture dissociation for top-down Fourier-transform mass spectrometry of integral membrane proteins. J Proteome Res 6 (2007) 2205-2210
21. Reeve Jr. J.R., Green G.M., Chew P., Eysselein V.E., and Keire D.A. CCK-58 is the only detectable endocrine form of cholecystokinin in rat. Am J Physiol Gastrointest Liver Physiol 285 (2003) G255-G265
22. Holst J.J. The physiology of glucagon-like peptide 1. Physiol Rev 87 (2007) 1409-1439
23. Eysselein V.E., Eberlein G.A., Grandt D., Schaeffer M., Zehres B., Behn U., Schaefer D., Goebell H., Davis M., Lee T.D., Shively J.E., Meyer H.E., and Reeve J.R.J. Structural characterization of canine PYY. Peptides 11 (1990) 111-116
24. Grandt D., Teyssen S., Schimiczek M., Reeve Jr. J., Feth F., Rascher W., Hirche H., Singer M.V., Layer P., Goebell H., Ho F.J., and Eysselein V.E. Novel generation of hormone receptor specificity by amino terminal processing of peptide YY. Biochem Biophys Res Commun 186 (1992) 1299-1306
25. Ahmad S., Wang L., and Ward P.E. Dipeptidyl(amino)peptidase IV and aminopeptidase M metabolize circulating substance P in vivo. J Pharmacol Exp Ther 260 (1992) 1257-1261
26. Wang L.H., Ahmad S., Benter I.F., Chow A., Mizutani S., and Ward P.E. Differential processing of substance P and neurokinin A by plasma dipeptidyl(amino)peptidase IV, aminopeptidase M and angiotensin converting enzyme. Peptides 12 (1991) 1357-1364
27. Mentlein R., Gallwitz B., and Schmidt W.E. Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum. Eur J Biochem 214 (1993) 829-835
28. Keire D.A., Vincent Wu S., Diehl D.L., Chew P., Ho F.J., Davis M.T., Lee T.D., Shively J.E., Walsh J.H., and Reeve Jr. J.R. Rat progastrin processing yields peptides with altered potency at the CCK-B receptor. Regul Pept 113 (2003) 115-124
29. Grandt D., Schimiczek M., Rascher W., Feth F., Shively J., Lee T.D., Davis M.T., Reeve Jr. J., and Michel M.C. Neuropeptide Y 3-36 is an endogenous ligand selective for Y2 receptors. Regul Pept 67 (1996) 33-37
30. Grandt D., Dahms P., Schimiczek M., Eysselein V.E., Reeve Jr. J.R., and Mentlein R. [Proteolytic processing by dipeptidyl aminopeptidase IV generates receptor selectivity for peptide YY (PYY)]. Med Klin (Munich) 88 (1993) 143-145
31. Hansen L., Deacon C.F., Orskov C., and Holst J.J. Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine. Endocrinology 140 (1999) 5356-5363
32. Michel M.C., Beck-Sickinger A., Cox H., Doods H.N., Herzog H., Larhammar D., Quirion R., Schwartz T., and Westfall T. XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev 50 (1998) 143-150
33. Yang H., Li W.P., Reeve J.R.J., Rivier J., and Tache Y. PYY-preferring receptor in the dorsal vagal complex and its involvement in PYY stimulation of gastric acid secretion in rats. Br J Pharmacol 123 8 (1998) 1549-1554
34. Movafagh S., Hobson J.P., Spiegel S., Kleinman H.K., and Zukowska Z. Neuropeptide Y induces migration, proliferation, and tube formation of endothelial cells bimodally via Y1, Y2, and Y5 receptors. Faseb J 20 (2006) 1924-1926
35. Keire D.A., Mannon P., Kobayashi M., Walsh J.H., Solomon T.E., and Reeve Jr. J.R. Primary structures of PYY, [Pro(34)]PYY, and PYY-(3-36) confer different conformations and receptor selectivity. Am J Physiol Gastrointest Liver Physiol 279 (2000) G126-G131
36. Boublik J.H., Scott N.A., Brown M.R., and Rivier J.E. Synthesis and hypertensive activity of neuropeptide Y fragments and analogues with modified N- or C-termini or D-substitutions. J Med Chem 32 (1989) 597-601
37. Gradin K.A., Buus C.L., Li J.Y., Frobert O., and Simonsen U. Neuropeptide Y2 receptors are involved in enhanced neurogenic vasoconstriction in spontaneously hypertensive rats. Br J Pharmacol 148 (2006) 703-713
38. Andrews P.C., Hawke D., Shively J.E., and Dixon J.E. A nonamidated peptide homologous to porcine peptide YY and neuropeptide YY. Endocrinology 116 (1985) 2677-2681
39. Balasubramaniam A., Andrews P.C., Renugopalakrishnan V., and Rigel D.F. Glycine-extended anglerfish peptide YG (aPY) a neuropeptide Y (NPY) homologue may be a precursor of a biologically active peptide. Peptides 10 (1989) 581-585
40. Milgram S.L., Balasubramaniam A., Andrews P.C., McDonald J.K., and Noe B.D. Characterization of aPY-like peptides in anglerfish brain using a novel radioimmunoassay for aPY-Gly. Peptides 10 (1989) 1013-1017
41. Orskov C., Rabenhoj L., Wettergren A., Kofod H., and Holst J.J. Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans. Diabetes 43 (1994) 535-539
42. Orskov C., Wettergren A., and Holst J.J. Biological effects and metabolic rates of glucagonlike peptide-1 7-36 amide and glucagonlike peptide-1 7-37 in healthy subjects are indistinguishable. Diabetes 42 (1993) 658-661
43. Valverde I., Morales M., Clemente F., Lopez-Delgado M.I., Delgado E., Perea A., and Villanueva-Penacarrillo M.L. Glucagon-like peptide 1: a potent glycogenic hormone. FEBS Lett 349 (1994) 313-316
44. Cui G.L., Sandvik A.K., Munkvold B., and Waldum H.L. Glycine-extended gastrin-17 stimulates acid secretion only via CCK-2 receptor-induced histamine release in the totally isolated vascularly perfused rat stomach. Acta Physiol Scand 174 (2002) 125-130
45. FitzGerald A.J., Ghatei M.A., Mandir N., Bloom S.R., Iversen L., and Goodlad R.A. Effects of amidated gastrin and glycine-extended gastrin on cell proliferation and crypt fission in parenterally and orally fed rats. Digestion 66 (2002) 58-66
46. Cain B.M., Wang W., and Beinfeld M.C. Cholecystokinin (CCK) levels are greatly reduced in the brains but not the duodenums of Cpe(fat)/Cpe(fat) mice: a regional difference in the involvement of carboxypeptidase E (Cpe) in pro-CCK processing. Endocrinology 138 (1997) 4034-4037
47. Wang W., Cain B.M., and Beinfeld M.C. Adult carboxypeptidase E-deficient fat/fat mice have a near-total depletion of brain CCK 8 accompanied by a massive accumulation of glycine and arginine extended CCK: identification of CCK 8 Gly as the immediate precursor of CCK 8 in rodent brain. Endocrine 9 (1998) 329-332
48. Oiry C., Pannequin J., Bernad N., Artis A.M., Galleyrand J.C., Devin C., Cristau M., Fehrentz J.A., and Martinez J. A synthetic glycine-extended bombesin analogue interacts with the GRP/bombesin receptor. Eur J Pharmacol 403 (2000) 17-25
49. Patel O., Dumesny C., Giraud A.S., Baldwin G.S., and Shulkes A. Stimulation of proliferation and migration of a colorectal cancer cell line by amidated and glycine-extended gastrin-releasing peptide via the same receptor. Biochem Pharmacol 68 (2004) 2129-2142
50. Zong Y., Reeve J.R.J., Walsh J.H., Gong P., Ho F.J., and Solomon T.E. Secretin-Gly is a major product of preprosecretin processing in rat small intestine: identification and quantitation by HPLC and radioimmunoassay (Abstract). Gastroenterology 114 (1998) A1197
51. Solomon T.E., Varga G., Zeng N., Wu S.V., Walsh J.H., and Reeve Jr. J.R. Different actions of secretin and Gly-extended secretin predict secretin receptor subtypes. Am J Physiol Gastrointest Liver Physiol 280 (2001) G88-G94
52. Solomon T.E., Walsh J.H., Bussjaeger L., Zong Y., Hamilton J.W., Ho F.J., Lee T.D., and Reeve Jr. J.R. COOH-terminally extended secretins are potent stimulants of pancreatic secretion. Am J Physiol 276 (1999) G808-G816
53. Fahrenkrug J. Glycine-extended processing intermediate of proVIP: a new form of VIP in the rat. Biochem Biophys Res Commun 178 (1991) 173-177
54. Fahrenkrug J., Ottesen B., and Palle C. Non-amidated forms of VIP (glycine-extended VIP and VIP-free acid) have full bioactivity on smooth muscle. Regul Pept 26 (1989) 235-239
55. Cauvin A., Vandermeers A., Vandermeers-Piret M.C., Rathe J., Robberecht P., and Christophe J. Peptide histidine isoleucinamide (PHI)-(1-27)-Gly as a new major form of PHI in the rat small intestine. Endocrinology 125 (1989) 1296-1302
56. Cauvin A., Vandermeers A., Vandermeers-Piret M.C., Robberecht P., and Christophe J. Variable distribution of three molecular forms of peptide histidine isoleucinamide in rat tissues: identification of the large molecular form as peptide histidine valine-(1-42). Endocrinology 125 (1989) 2645-2655
57. Cauvin A., Vandermeers-Piret M.C., Vandermeers A., Coussaert E., de Neef P., Robberecht P., and Christophe J. Rat PHI, PHI-GLY and PHV (1-42) stimulate adenylate cyclase in six rat tissue and cell membranes. Peptides 11 (1990) 1009-1014
58. Lefebvre R.A., Sas S., and Cauvin A. Relaxant effect of rat PHI, PHI-Gly and PHV(1-42) in the rat gastric fundus. Peptides 12 (1991) 271-274
59. Ghillani P., Motte P., Bohuon C., and Bellet D. Monoclonal antipeptide antibodies as tools to dissect closely related gene products. A model using peptides encoded by the calcitonin gene. J Immunol 141 (1988) 3156-3163
60. Katafuchi T., Hamano K., Kikumoto K., and Minamino N. Isolation and characterization of a glycine-extended form of calcitonin receptor-stimulating peptide-1: another biologically active form of calcitonin receptor-stimulating peptide-1. Peptides 26 (2005) 2616-2623
61. Marchand J.E., Shimonaka H., and Kream R.M. Biochemical characterization and anatomical distribution of a major form of unamidated precursor of substance P in rat brain. Brain Res 567 (1991) 290-305
62. Oldham C.D., Li C., Feng J., Scott R.O., Wang W.Z., Moore A.B., Girard P.R., Huang J., Caldwell R.B., Caldwell R.W., and May S.W. Amidative peptide processing and vascular function. Am J Physiol 273 (1997) C1908-C1914
63. Fenger M. Alpha-melanocyte-stimulating-hormone precursors in the pig pituitary. Biochem J 235 (1986) 715-722
64. Simard M., Pekary A.E., Smith V.P., and Hershman J.M. Thyroid hormone modulation of TRH precursor levels in rat hypothalamus, pituitary, thyroid and blood. Peptides 10 (1989) 145-155
65. Stephens Jr. R.L., Pekary A.E., DiStephano III J.J., Landaw E., and Tache Y. Intracisternal injection of TRH precursor, TRH-glycine, stimulates gastric acid secretion in rats. Regul Pept 25 (1989) 51-60
66. Mori M., Murakami M., Iriuchijima T., Miyashita K., Satoh T., Monden T., Michimata T., Kobayashi I., and Kobayashi S. Stimulation by a TRH precursor, TRH-Gly, of TSH and PRL secretion in rats: effect of starvation. Neuropeptides 16 (1990) 57-62
67. Mori M., Murakami M., Satoh T., Miyashita K., Iriuchijima T., Yamada M., Inukai T., and Kobayashi I. A possible direct precursor of thyrotropin-releasing hormone, pGlu-His-Pro-Gly, stimulates prolactin secretion in anorexia nervosa. J Clin Endocrinol Metab 71 (1990) 252-255
68. Mori M., Satoh T., Miyashita K., Yamada M., Murakami M., Iriuchijima T., Ohshima K., Kobayashi I., and Kobayashi S. TRH-Gly, a precursor of TRH, alters GH secretion in acromegaly. Life Sci 49 (1991) 1031-1037
69. Yamada M., Iwasaki T., Satoh T., Monden T., Konaka S., Murakami M., Iriuchijima T., and Mori M. Activation of the thyrotropin-releasing hormone (TRH) receptor by a direct precursor of TRH, TRH-Gly. Neurosci Lett 196 (1995) 109-112
70. Kaiya H., Small B.C., Bilodeau A.L., Shepherd B.S., Kojima M., Hosoda H., and Kangawa K. Purification, cDNA cloning, and characterization of ghrelin in channel catfish, Ictalurus punctatus. Gen Comp Endocrinol 143 (2005) 201-210
71. Kitamura K., Kato J., Kawamoto M., Tanaka M., Chino N., Kangawa K., and Eto T. The intermediate form of glycine-extended adrenomedullin is the major circulating molecular form in human plasma. Biochem Biophys Res Commun 244 (1998) 551-555
72. Cao Y.N., Kitamura K., Ito K., Kato J., Hashida S., Morishita K., and Eto T. Glycine-extended adrenomedullin exerts vasodilator effect through amidation in the rat aorta. Regul Pept 113 (2003) 109-114